6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Originaltext

Diese Übersetzung bewerten

Mit deinem Feedback können wir Google Übersetzer weiter verbessern

Latest Press Releases

Time	Headline
8m ago	CC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
41m ago	Canadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
41m ago	Waraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
41m ago	Sierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
41m ago	First Quantum Minerals Reports First Quarter 2026 Results

About

Outlook Therapeutics Inc (NASDAQ:OTLK) — investor relations, events, news, and company updates on 6ix.

Latest News

Outlook Therapeutics Announces Closing of $5.0 Million Registered Direct Offering

Outlook Therapeutics Announces $5.0 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Outlook Therapeutics Completes Federal Dispute Resolution (FDR) Meeting with FDA for ONS-5010/LYTENAVA™ (bevacizumab-vikg)

Outlook Therapeutics Announces Formal Dispute Resolution Request for ONS-5010/LYTENAVA™ (bevacizumab-vikg) Accepted by FDA

Outlook Therapeutics Announces Closing of $5.0 Million Public Offering

Financials

Revenue

$205.7 K

Market Cap

$20.99 M

EPS

-2.89

Community Chat

Ask AI